DHX58 and early-onset autosomal dominant Alzheimer disease: Additionally, the TREAT-AD (TaRget Enablement to Accelerate Therapy development for Alzheimer’s Disease) Center has identified MDA5, LGP2, and DDX1 as potential risk factors in Alzheimer’s disease progression 22.